SCHEMBL26428540

SCHEMBL26428540

COC(=O)c1cccc(C2CNC2)n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.45
MAPT P10636 4/20 0.43
CYP1A2 P05177 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GAA P10253 1/20 0.43
RECQL P46063 1/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RAB9A P51151 1/20 0.43
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
GRM5 P41594 1/20 0.40
PARP1 P09874 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31284724 0.89 CNR2 (0.44) CNR2MAPTCYP1A2SMN1; SMN2GAA
SCHEMBL23530104 0.86 CNR2 (0.54) CNR2MAPTCYP1A2SMN1; SMN2GAA
SCHEMBL410932 0.85 CNR2 (0.49) CNR2MAPTCYP1A2SMN1; SMN2GAA
SCHEMBL412412 0.78 CNR2 (0.49) CNR2MAPTCYP1A2SMN1; SMN2GAA
SCHEMBL22235457 0.77 CNR2 (0.50) CNR2MAPTCYP1A2SMN1; SMN2GAA
SCHEMBL23106869 0.76 CNR2 (0.34) CNR2CHRNB2CHRNA4PARP1
SCHEMBL27372368 0.76 CNR2 (0.49) CNR2MAPTCYP1A2SMN1; SMN2GAA
SCHEMBL30755591 0.76 CNR2 (0.49) CNR2MAPTCYP1A2SMN1; SMN2GAA
SCHEMBL69653 0.76 MAPT (0.64) MAPTCYP1A2SMN1; SMN2GAARECQL
SCHEMBL17478778 0.75 CNR2 (0.43) CNR2MAPTCYP1A2SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067353-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 WO disclosed